This Week's ETF Winners & Losers

04/13/07 - 04:52 PM EDT

Robert Holmes

Health-care and biotechnology exchange-traded funds were among the best performers in the ETF world this week, thanks to positive action from MedImmune (MEDI Quote) and Merck (MRK Quote).

On Thursday, MedImmune jumped 15.3% after it indicated the possibility of a sale of the company. On Friday, Merck jumped 8.3% after lifting its full-year earnings-per-share forecast by 20 cents.

The Pharmaceutical HOLDRs (PPH Quote) ETF was higher for the week by 3.8%, closing at $82.71. The HealthShares Emerging Cancer (HHJ Quote) added 1.2% over the five sessions to end at $27.13.

ETFs tracking metals and mining were also among weekly winners. Gold futures gained roughly 1.5% over the five sessions to close at $689.90 an ounce, and silver futures rose 2.5% to end at $14.09 an ounce.

For the week, the iShares Silver Trust (SLV Quote) was higher by 2.4% to close at $139.90. The streetTRACKS Gold Shares (GLD Quote) ETF added 1.5% to $67.84. The iShares Comex Gold Trust (IAU Quote) tacked on 1.4% to $67.91.

The iShares Dow Jones Transportation Average (IYT Quote) ETF was another of the week's winners. On Monday, rail concern Burlington Northern Santa Fe (BNI Quote) jumped after a Securities and Exchange Commission filing stated that billionaire investor Warren Buffett's Berkshire Hathaway (BRK.A Quote) had purchased a 10.9% stake in the company, making it the largest shareholder.

The ETF, which was also aided by lower crude prices for the week, rose $2, or 2.3%, to $90.10.

< Previous
1 2
Your Recent Quotes: Quote Up0 | Quote Down0
 
Dow S&P 500 NASDAQ
Oil*
64.18
8,324.87
898.72
1,787.40
10 Yr
3.51%
44.13
2.30
9.12
+0.53%
+0.26%
-0.51%
Data delayed 20 min
Get Jim Cramer's Free Newsletter

The Daily Booyah!
Get your daily dose of Cramer in your inbox.
Submit
We respect your privacy.

Premium Stock Ideas
Access Action Alerts Plus to find out Cramer's latest picks now!

Brokerage Partners